Onychomycosis

31.05.2018
Therapy of patients with mild, moderate and severe onychomycosis by the munich model (ND:YAG laser and co-treatment with topical antimycotic therapy): adjuvant short.time and low-dose treatment with itraconazole can optimize the result

In the western world, about 10% of the population is affected by fungal nail changes and there is a massive accumulation in older people, especially after the age of 60, […]

News

08.10.2018
Food activates brown fat

Brown fat consumes energy, which is the reason why it could be important for preventing obesity and diabetes. Working together with an international team, researchers at the Technical University of […]

23.01.2021
The lower face: shaping and contouring with fillers from the Galderma portfolio*

* Lunch symposium “The lower third of the face – treatment challenges and optimal product selection (hyaluron-filler)” at the 50th Annual Meeting of the German Society of Plastic, Reconstructive and […]

23.09.2023
Focus on hyperpigmentation:

Treatment options and combination therapy in everyday practice Hyperpigmentation plays a major role in the daily routine of dermatologists. Solar radiation, stress and various noxae are regarded as triggers for […]

Onychomycosis

31.05.2018 Therapy of patients with mild, moderate and severe onychomycosis by the munich model (ND:YAG laser and co-treatment with topical antimycotic therapy): adjuvant short.time and low-dose treatment with itraconazole can optimize the result

News

08.10.2018 Food activates brown fat

23.01.2021 The lower face: shaping and contouring with fillers from the Galderma portfolio*

23.09.2023 Focus on hyperpigmentation:

Login

Forgotten Password?

31.05.2018
Therapy of patients with mild, moderate and severe onychomycosis by the munich model (ND:YAG laser and co-treatment with topical antimycotic therapy): adjuvant short.time and low-dose treatment with itraconazole can optimize the result

08.10.2018
Food activates brown fat

23.01.2021
The lower face: shaping and contouring with fillers from the Galderma portfolio*

23.09.2023
Focus on hyperpigmentation: